1. Home
  2. MNKD vs GAM Comparison

MNKD vs GAM Comparison

Compare MNKD & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • GAM
  • Stock Information
  • Founded
  • MNKD 1991
  • GAM 1927
  • Country
  • MNKD United States
  • GAM United States
  • Employees
  • MNKD N/A
  • GAM N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • GAM Investment Managers
  • Sector
  • MNKD Health Care
  • GAM Finance
  • Exchange
  • MNKD Nasdaq
  • GAM Nasdaq
  • Market Cap
  • MNKD 1.2B
  • GAM 1.3B
  • IPO Year
  • MNKD 2004
  • GAM N/A
  • Fundamental
  • Price
  • MNKD $3.73
  • GAM $59.15
  • Analyst Decision
  • MNKD Buy
  • GAM
  • Analyst Count
  • MNKD 6
  • GAM 0
  • Target Price
  • MNKD $9.17
  • GAM N/A
  • AVG Volume (30 Days)
  • MNKD 3.1M
  • GAM 20.1K
  • Earning Date
  • MNKD 08-06-2025
  • GAM 01-01-0001
  • Dividend Yield
  • MNKD N/A
  • GAM 5.74%
  • EPS Growth
  • MNKD 149.32
  • GAM N/A
  • EPS
  • MNKD 0.11
  • GAM 11.67
  • Revenue
  • MNKD $301,736,000.00
  • GAM N/A
  • Revenue This Year
  • MNKD $13.62
  • GAM N/A
  • Revenue Next Year
  • MNKD $15.18
  • GAM N/A
  • P/E Ratio
  • MNKD $34.33
  • GAM $3.95
  • Revenue Growth
  • MNKD 21.48
  • GAM N/A
  • 52 Week Low
  • MNKD $3.38
  • GAM $37.32
  • 52 Week High
  • MNKD $7.63
  • GAM $46.48
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 48.69
  • GAM 71.38
  • Support Level
  • MNKD $3.60
  • GAM $57.55
  • Resistance Level
  • MNKD $3.81
  • GAM $59.68
  • Average True Range (ATR)
  • MNKD 0.17
  • GAM 0.65
  • MACD
  • MNKD -0.00
  • GAM 0.11
  • Stochastic Oscillator
  • MNKD 50.72
  • GAM 84.46

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About GAM General American Investors Inc.

General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.

Share on Social Networks: